Nobivac DP Plus


Canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant)

This medicine is authorised for use in the European Union.


Nobivac DP Plus is a veterinary vaccine used to protect dogs against two separate infections caused by canine distemper virus and canine parvovirus.

Nobivac DP Plus contains the active substances live attenuated (weakened) canine distemper virus (CDV) and canine parvovirus (CPV).

This EPAR was last updated on 23/08/2021

Authorisation details

Product details
Nobivac DP Plus
Agency product number
Active substance
  • Live attenuated canine distemper virus strain Onderstepoort: 105.1 – 106.5 TCID50
  • Live recombinant canine parvovirus strain 630a: 105.1 – 106.7 TCID50
International non-proprietary name (INN) or common name
Canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant)
Dogs (small)
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Intervet International B.V.
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

09/12/2020 Nobivac DP Plus - EMEA/V/C/005251 -

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Immunologicals for canidae

Therapeutic indication

For the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Assessment history

How useful was this page?

Add your rating
1 rating